SERIAL PROSTATE-SPECIFIC ANTIGEN MEASUREMENTS AND PROGRESSION IN UNTREATED CONFINED (STAGE-T0 TO STAGE-3NXMO, GRADE-1 TO GRADE-3) CARCINOMA OF THE PROSTATE

被引:9
作者
BANGMA, CH
HOP, WCJ
SCHRODER, FH
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT BIOSTAT & EPIDEMIOL, 3000 DR ROTTERDAM, NETHERLANDS
[2] ACAD HOSP, ROTTERDAM, NETHERLANDS
关键词
PROSTATIC NEOPLASMS; ANTIGENS; NEOPLASM; FOLLOW-UP STUDIES; NEOPLASM METASTASIS;
D O I
10.1016/S0022-5347(01)66877-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The contribution of serial prostate specific antigen (PSA) determinations was studied to obtain better understanding of the natural history of clinically confined prostate carcinoma. Materials and Methods: Serial PSA determinations in 29 patients with untreated confined prostate carcinoma were correlated to the clinical course for a mean of 39 months. Results: Disease progressed locally in 13 patients after a mean of 31 months. Metastatic progression was not observed. Neither grade, stage, PSA changes nor initial PSA showed significant differences with respect to interval of progression between patients with and without progression. Conclusions: PSA does not parallel clinical progression in patients selected for watchful waiting.
引用
收藏
页码:1403 / 1406
页数:4
相关论文
共 23 条
[1]   PROSTATE-SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION IN LONG-TERM FOLLOW-UP OF STATE-A1 PROSTATIC-CARCINOMA [J].
BELVILLE, WD ;
VACCARO, JA ;
KIESLING, VJ .
UROLOGY, 1992, 39 (06) :586-588
[2]   LONG-TERM FOLLOW-UP OF YOUNG-PATIENTS WITH STAGE-A ADENOCARCINOMA OF THE PROSTATE [J].
BLUTE, ML ;
ZINCKE, H ;
FARROW, GM .
JOURNAL OF UROLOGY, 1986, 136 (04) :840-843
[3]   PROSTATE-SPECIFIC ANTIGEN IN MANAGEMENT OF PROSTATIC-CARCINOMA [J].
BRAWER, MK ;
LANGE, PH .
UROLOGY, 1989, 33 (05) :11-16
[4]   SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE-SPECIFIC ANTIGEN - RESULTS OF THE 2ND-YEAR [J].
BRAWER, MK ;
BEATIE, J ;
WENER, MH ;
VESSELLA, RL ;
PRESTON, SD ;
LANGE, PH .
JOURNAL OF UROLOGY, 1993, 150 (01) :106-109
[5]  
BRAWN PN, 1982, CANCER, V49, P525, DOI 10.1002/1097-0142(19820201)49:3<525::AID-CNCR2820490321>3.0.CO
[6]  
2-M
[7]   RELATIONSHIP BETWEEN CHANGES IN PROSTATE-SPECIFIC ANTIGEN AND PROGNOSIS OF PROSTATE-CANCER [J].
CADEDDU, JA ;
PEARSON, JD ;
PARTIN, AW ;
EPSTEIN, JI ;
CARTER, HB .
UROLOGY, 1993, 42 (04) :383-389
[8]   HETEROZYGOUS CYSTINURIA AND CALCIUM-OXALATE UROLITHIASIS [J].
CARPENTIER, PJ ;
KURTH, KH ;
BLOM, W ;
HUIJMANS, JGM .
JOURNAL OF UROLOGY, 1983, 130 (02) :302-304
[9]   LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].
CARTER, HB ;
PEARSON, JD ;
METTER, J ;
BRANT, LJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
WALSH, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220
[10]   RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER [J].
CHODAK, GW ;
THISTED, RA ;
GERBER, GS ;
JOHANSSON, JE ;
ADOLFSSON, J ;
JONES, GW ;
CHISHOLM, GD ;
MOSKOVITZ, B ;
LIVNE, PM ;
WARNER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :242-248